HPC Biosciences Ltd. reported audited standalone earnings results for the six months and full year ended March 31, 2015. For the six months, net sales/income from operation was INR 16,481,990.00, profit from operation before other income, interest and exceptional item was INR 2,898,234.50, profit from ordinary activities before tax was INR 2,898,234.50 and net profit was INR 2,565,589.97 or INR 0.02 per basic and diluted share.
 
For the year, net sales/income from operation was INR 30,944,378.00 against INR 34,616,606.00 a year ago. Profit from operation before other income, interest and exceptional item was INR 7,567,122.12 against INR 12,557,557.40 a year ago. Profit from ordinary activities before tax was INR 7,567,122.12 against INR 12,557,557.40 a year ago. Net profit was INR 7,050,563.57 or INR 0.04 per basic and diluted share against INR 12,358,483.40 or INR 0.04 per basic and diluted share a year ago.